Virios Therapeutics VIRI Stock
Virios Therapeutics Price Chart
Virios Therapeutics VIRI Financial and Trading Overview
| Virios Therapeutics stock price | 0.51 USD |
| Previous Close | 1.94 USD |
| Open | 1.93 USD |
| Bid | 0 USD x 800 |
| Ask | 0 USD x 800 |
| Day's Range | 1.83 - 1.96 USD |
| 52 Week Range | 0.22 - 9.11 USD |
| Volume | 378.79K USD |
| Avg. Volume | 2.97M USD |
| Market Cap | 33.91M USD |
| Beta (5Y Monthly) | 2.013136 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.28 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
VIRI Valuation Measures
| Enterprise Value | 30.23M USD |
| Trailing P/E | N/A |
| Forward P/E | -6.3793106 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 5.6748466 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Virios Therapeutics Stock Price History
| Beta (5Y Monthly) | 2.013136 |
| 52-Week Change | -52.31% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.11 USD |
| 52 Week Low | 0.22 USD |
| 50-Day Moving Average | 1.09 USD |
| 200-Day Moving Average | 0.98 USD |
VIRI Share Statistics
| Avg. Volume (3 month) | 2.97M USD |
| Avg. Daily Volume (10-Days) | 600.01K USD |
| Shares Outstanding | 18.33M |
| Float | 15.39M |
| Short Ratio | 0.39 |
| % Held by Insiders | 12.05% |
| % Held by Institutions | 10.70% |
| Shares Short | 414.27K |
| Short % of Float | 2.39% |
| Short % of Shares Outstanding | 2.25% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -64.96% |
| Return on Equity (ttm) | -117.81% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -9804390 USD |
| Diluted EPS (ttm) | -0.8 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 5.33M USD |
| Total Cash Per Share (mrq) | 0.29 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 11.871 |
| Book Value Per Share (mrq) | 0.326 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -10510230 USD |
| Levered Free Cash Flow (ttm) | -6900454 USD |
Profile of Virios Therapeutics
| Country | United States |
| State | GA |
| City | Alpharetta |
| Address | 44 Milton Avenue |
| ZIP | 30009 |
| Phone | 866-620-8655 |
| Website | https://www.virios.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 4 |
Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Innovative Med Concepts, LLC and changed its name to Virios Therapeutics, Inc. in July 2020. Virios Therapeutics, Inc. was founded in 2012 and is headquartered in Alpharetta, Georgia.
Q&A For Virios Therapeutics Stock
What is a current VIRI stock price?
Virios Therapeutics VIRI stock price today per share is 0.51 USD.
How to purchase Virios Therapeutics stock?
You can buy VIRI shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Virios Therapeutics?
The stock symbol or ticker of Virios Therapeutics is VIRI.
Which industry does the Virios Therapeutics company belong to?
The Virios Therapeutics industry is Biotechnology.
How many shares does Virios Therapeutics have in circulation?
The max supply of Virios Therapeutics shares is 19.26M.
What is Virios Therapeutics Price to Earnings Ratio (PE Ratio)?
Virios Therapeutics PE Ratio is now.
What was Virios Therapeutics earnings per share over the trailing 12 months (TTM)?
Virios Therapeutics EPS is -0.28 USD over the trailing 12 months.
Which sector does the Virios Therapeutics company belong to?
The Virios Therapeutics sector is Healthcare.
Virios Therapeutics VIRI included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}